These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2111054)

  • 21. The effect of the pyrrolizidine alkaloids, monocrotaline and trichodesmine, on tissue pyrrole binding and glutathione metabolism in the rat.
    Yan CC; Huxtable RJ
    Toxicon; 1995 May; 33(5):627-34. PubMed ID: 7660367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 7-cysteine-pyrrole conjugate: A new potential DNA reactive metabolite of pyrrolizidine alkaloids.
    He X; Xia Q; Ma L; Fu PP
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2016; 34(1):57-76. PubMed ID: 26761716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excretion of pyrrolic metabolites in the bile of rats given the pyrrolizidine alkaloid retrorsine or the bis-N-ethylcarbamate of synthanecine A.
    White IN
    Chem Biol Interact; 1977 Feb; 16(2):169-80. PubMed ID: 849622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of pyrrolizidine alkaloid metabolites from mouse liver microsomes using tandem mass spectrometry and gas chromatography/mass spectrometry.
    Winter CK; Segall HJ; Jones AD
    Biomed Environ Mass Spectrom; 1988 Mar; 15(5):265-73. PubMed ID: 3365497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [14C]monocrotaline kinetics and metabolism in the rat.
    Estep JE; Lamé MW; Morin D; Jones AD; Wilson DW; Segall HJ
    Drug Metab Dispos; 1991; 19(1):135-9. PubMed ID: 1673386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyrrolizidine Alkaloid Secondary Pyrrolic Metabolites Construct Multiple Activation Pathways Leading to DNA Adduct Formation and Potential Liver Tumor Initiation.
    Xia Q; He X; Ma L; Chen S; Fu PP
    Chem Res Toxicol; 2018 Jul; 31(7):619-628. PubMed ID: 29855181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The formation of 6,7-dihydro-7-hydroxy-1-hydroxy-methyl-5H-pyrrolizine, a metabolite of pyrrolizidine alkaloids.
    Kedzierski B; Buhler DR
    Chem Biol Interact; 1986 Feb; 57(2):217-22. PubMed ID: 3955792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the pyrrolizidine alkaloid, monocrotaline, on bile composition of the isolated, perfused rat liver.
    Yan CC; Huxtable RJ
    Life Sci; 1995; 57(6):617-26. PubMed ID: 7623629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
    Xia Q; Yan J; Chou MW; Fu PP
    Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the pneumotoxicity of some pyrrolic esters and similar compounds analogous to pyrrolizidine alkaloid metabolites, given intravenously to rats.
    Mattocks AR; Driver HE
    Toxicology; 1983 Jun; 27(2):159-77. PubMed ID: 6612746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GC/MS/MS detection of pyrrolic metabolites in animals poisoned with the pyrrolizidine alkaloid riddelliine.
    Schoch TK; Gardner DR; Stegelmeier BL
    J Nat Toxins; 2000 May; 9(2):197-206. PubMed ID: 10868345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic activation of pyrrolizidine alkaloids by human, rat and avocado microsomes.
    Couet CE; Hopley J; Hanley AB
    Toxicon; 1996 Sep; 34(9):1058-61. PubMed ID: 8896199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of glutathione and cysteine on pyrrolizidine alkaloid-induced hepatotoxicity and DNA adduct formation in rat primary hepatocytes.
    He X; Xia Q; Shi Q; Fu PP
    J Environ Sci Health C Toxicol Carcinog; 2020; 38(2):109-123. PubMed ID: 32500832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of DNA adducts derived from riddelliine, a carcinogenic pyrrolizidine alkaloid.
    Chou MW; Jian Y; Williams LD; Xia Q; Churchwell M; Doerge DR; Fu PP
    Chem Res Toxicol; 2003 Sep; 16(9):1130-7. PubMed ID: 12971801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfur conjugates as putative pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Huxtable RJ; Bowers R; Mattocks AR; Michnicka M
    Adv Exp Med Biol; 1991; 283():605-12. PubMed ID: 1906228
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanisms for pyrrolizidine alkaloid activation and detoxification.
    Buhler DR; Miranda CL; Kedzierski B; Reed RL
    Adv Exp Med Biol; 1991; 283():597-603. PubMed ID: 2069028
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization of rat liver microsomal metabolites of clivorine, an hepatotoxic otonecine-type pyrrolizidine alkaloid.
    Lin G; Cui YY; Hawes EM
    Drug Metab Dispos; 2000 Dec; 28(12):1475-83. PubMed ID: 11095586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation in vitro of several pyrrolizidine alkaloid carcinogens: observations on the essential pyrrolic nucleus.
    Styles J; Ashby J; Mattocks AR
    Carcinogenesis; 1980 Feb; 1(2):161-4. PubMed ID: 22282996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinogenicity of some pyrrolic pyrrolizidine alkaloid metabolites and analogues.
    Mattocks AR; Cabral JR
    Cancer Lett; 1982 Oct; 17(1):61-6. PubMed ID: 6817913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.